Published in Cancer Treat Rep on November 01, 1978
Application of tumor, bacterial and parasite susceptibility assays to study immune alterations induced by environmental chemicals. Environ Health Perspect (1982) 0.92
Antimicrobial activity of various immunomodulators: independence from normal levels of circulating monocytes and natural killer cells. Infect Immun (1986) 0.83
Resistance to infections in mice with defects in the activities of mononuclear phagocytes and natural killer cells: effects of immunomodulators in beige mice and 89Sr-treated mice. Infect Immun (1982) 0.79
Career intentions of medical students trained in six sub-Saharan African countries. Educ Health (Abingdon) (2011) 2.54
Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture. J Cell Biol (1982) 2.17
Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol (1992) 1.83
Macrophage nomenclature: where are we going? J Reticuloendothel Soc (1980) 1.81
Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam Appl Toxicol (1988) 1.71
Measuring the effects of an international health professions faculty development fellowship: the FAIMER Institute. Med Teach (2010) 1.68
Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem Toxicol (1999) 1.62
Isolation of human serum spreading factor. J Biol Chem (1983) 1.61
Extended culture of mouse embryo cells without senescence: inhibition by serum. Science (1987) 1.43
Comparison of antiviral and antitumor activity of activated macrophages. Cell Immunol (1977) 1.42
Age-related cellular resistance of the chicken embryo to viral infections. I. Interferon and natural resistance to myxoviruses and vesicular stomatitis virus. J Infect Dis (1970) 1.42
Kinetics of changes in peritoneal cell populations following acute inflammation. Cell Immunol (1989) 1.37
Macrophage extrinsic antiviral activity during herpes simplex virus infection. J Gen Virol (1980) 1.34
Characterization of human serum spreading factor with monoclonal antibody. Proc Natl Acad Sci U S A (1983) 1.33
Subchronic 10 day immunotoxicity of polydimethylsiloxane (silicone) fluid, gel and elastomer and polyurethane disks in female B6C3F1 mice. Drug Chem Toxicol (1994) 1.23
Induction of macrophage-mediated tumor-cell cytotoxicity by pyran copolymer. J Natl Cancer Inst (1974) 1.23
Innovative mentoring programs to promote gender equity in academic medicine. Acad Med (2001) 1.23
Review of the macrophage disappearance reaction. J Leukoc Biol (1995) 1.20
Viruses and the versatile macrophage. Br Med Bull (1985) 1.15
Antineoplastic activity of cannabinoids. J Natl Cancer Inst (1975) 1.14
Immunomodulator-induced resistance against herpes simplex virus. Proc Soc Exp Biol Med (1977) 1.14
Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation. J Cell Biol (1991) 1.13
Changes in macrophage ectoenzymes associated with anti-tumor activity. J Immunol (1980) 1.13
CNS diseases associated with varicella zoster virus and herpes simplex virus infection. Pathogenesis and current therapy. Neurol Clin (1986) 1.12
Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2. J Immunol (1977) 1.12
Macrophage functions in beige (Chédiak-Higashi syndrome) mice. Cancer Res (1980) 1.11
Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine. Infect Immun (1977) 1.09
Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide. Fundam Appl Toxicol (1993) 1.07
Local origin of fibroblasts deduced from sarcomas induced in chimaeras by implants of pliable disks. Nature (1971) 1.06
Stimulation of haptotaxis and migration of tumor cells by serum spreading factor. Cancer Res (1985) 1.06
Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: role of reactive oxygen species. J Immunol (1997) 1.06
Comparison of mouse strains using the local lymph node assay. Toxicology (2000) 1.05
Capacity building in medical education and health outcomes in developing countries: the missing link. Educ Health (Abingdon) (2007) 1.05
Haemopoietic stem cells in the peripheral blood. Lancet (1967) 1.05
Continuous in vitro propagation and differentiation of cultures of the intramolluscan stages of the human parasite Schistosoma mansoni. Proc Natl Acad Sci U S A (1999) 1.04
Quantitation of spreading factor in human biologic fluids. J Lab Clin Med (1984) 1.04
Repression of interferon action: induced dedifferentiation of embryonic cells. Science (1971) 1.03
Heparin-binding properties of human serum spreading factor. J Biol Chem (1985) 1.03
Norepinephrine and the antibody response. Pharmacol Rev (1985) 1.03
Toxicology of chloral hydrate in the mouse. Environ Health Perspect (1982) 1.02
Binding of Staphylococcus aureus by human serum spreading factor in an in vitro assay. Infect Immun (1986) 1.02
Stimulation of sugar uptake and thymidine incorporation in mouse 3T3 cells by calcium phosphate and other extracellular particles. Proc Natl Acad Sci U S A (1977) 1.02
Advancing women and closing the leadership gap: the Executive Leadership in Academic Medicine (ELAM) program experience. J Womens Health Gend Based Med (2001) 1.02
Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1. Infect Immun (1981) 1.01
Zebrafish (Danio rerio) p53 tumor suppressor gene: cDNA sequence and expression during embryogenesis. Mol Mar Biol Biotechnol (1997) 1.01
Differential effects of chronic monocyte depletion on macrophage populations. Lab Invest (1983) 1.01
Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect Immun (1979) 0.99
Biphasic response of the reticuloendothelial system (RES) induced by pyran copolymer. J Reticuloendothel Soc (1970) 0.98
Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. J Interferon Res (1990) 0.98
ES-like cell cultures derived from early zebrafish embryos. Mol Mar Biol Biotechnol (1995) 0.98
Effects of fibronectin-related peptides on cell spreading. In Vitro Cell Dev Biol (1985) 0.97
Effects of an air-powder polishing system on orthodontically bracketed and banded teeth. Am J Orthod Dentofacial Orthop (1990) 0.96
Effect of inapparent murine hepatitis virus infections on macrophages and host resistance. J Leukoc Biol (1986) 0.96
Effect of Tilorone hydrochloride and congeners on reticuloendothelial system, tumors, and the immune response. Cancer Res (1972) 0.96
Fibroblasts in sterile inflammation: study in mouse radiation chimaeras. Nature (1968) 0.96
Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fundam Appl Toxicol (1989) 0.96
A multisite collaborative for the development of interdisciplinary education in continuous improvement for health professions students. Acad Med (1996) 0.95
Antiviral activity and side effects of polyriboinosinic-cytidylic acid complexes as affected by molecular size. Proc Natl Acad Sci U S A (1972) 0.93
Stability of minute virus of mice to chemical and physical agents. Appl Microbiol (1974) 0.93
90Sr-induced osteosarcomas in radiation chimaeras. Int J Radiat Biol Relat Stud Phys Chem Med (1970) 0.93
Selective depletion of liver and splenic macrophages using liposomes encapsulating the drug dichloromethylene diphosphonate: effects on antimicrobial resistance. J Leukoc Biol (1991) 0.92
Humoral and cell-mediated immune status in mice exposed to chloral hydrate. Environ Health Perspect (1982) 0.92
Activated macrophages mediate interferon-independent inhibition of herpes simplex virus. Cell Immunol (1981) 0.92
Macrophage activation and anti-tumor activity of biologic and synthetic agents. Int J Cancer (1976) 0.91
Comparison of various macrophage-inhibitory agents on vaginal and systemic herpes simplex virus type 2 infections. Infect Immun (1978) 0.91
Effect of pyran on latency after herpes simplex virus infections. Antimicrob Agents Chemother (1979) 0.91
Maintenance of peritoneal macrophages in the steady state. J Leukoc Biol (1988) 0.91
Qualitative and quantitative experimental models to aid in risk assessment for immunotoxicology. Toxicol Lett (1992) 0.90
Induction of zebrafish (Brachydanio rerio) P450 in vivo and in cell culture. Xenobiotica (1994) 0.90
Regulation of cytochrome P450 expression in a novel liver cell line from zebrafish (Brachydanio rerio). Arch Biochem Biophys (1993) 0.89
Implementing a comprehensive approach to managing faculty roles, rewards, and development in an era of change. Acad Med (1997) 0.89
Role of sensitization routes in the development of type I hypersensitivity to natural rubber latex in mice. Am J Ind Med (1999) 0.89
Pyran and polyribonucleotides: differences in biological activities. Antimicrob Agents Chemother (1972) 0.89
An immunotoxicological evaluation of 4,4'-thiobis-(6-t-butyl-m-cresol) in female B6C3F1 mice. 2. Humoral and cell-mediated immunity, macrophage function, and host resistance. Fundam Appl Toxicol (1988) 0.88
Tissue localization studies in evaluating the functional role of the RES. J Reticuloendothel Soc (1970) 0.88
Culture of cells from zebrafish (Brachydanio rerio) embryo and adult tissues. Cell Biol Toxicol (1992) 0.88
Decreases in macrophage mediated antitumor activity with aging. Mech Ageing Dev (1995) 0.88
Age-related cellular resistance of the chicken embryo to viral infections. II. Inducible resistance produced by influenza virus and Escherichia coli. J Infect Dis (1970) 0.88
Effects of irradiation and antigenic stimulation on circulating haemopoietic stem cells of the mouse. Nature (1967) 0.88
Macrophage mediated tumor cell cytotoxicity. Ann N Y Acad Sci (1976) 0.87
Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell Immunol (1988) 0.87
The effects of maleic anhydride-divinyl ether (MVE) copolymers on hepatic microsomal mixed-function oxidases and other biologic activities. J Pharmacol Exp Ther (1979) 0.87
Identification of a macrophage-specific cell surface antigen. J Immunol (1976) 0.87
Effect of bacterial lipopolysaccharide, lipid A, and concanavalin A on lethality of 5-fluorouracil for mice. Toxicol Appl Pharmacol (1975) 0.87
Comparative study of various immunomodulators for macrophage and natural killer cell activation and antiviral efficacy against exotic RNA viruses. Int J Immunopharmacol (1988) 0.87
Basic fibroblast growth factor stimulates proliferation and suppresses melanogenesis in cell cultures derived from early zebrafish embryos. Mol Mar Biol Biotechnol (1994) 0.86
Selection of transformed cells in serum-free media. In Vitro Cell Dev Biol (1985) 0.86
Induction of hypoxia in normal and malignant tissues by changing the oxygen affinity of hemoglobin--implications for therapy. Int J Radiat Oncol Biol Phys (1986) 0.86
Evidence for arsenic as the immunosuppressive component of gallium arsenide. Toxicol Appl Pharmacol (1991) 0.86
Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice. Toxicol Appl Pharmacol (2001) 0.86
Resistance to vaginal or systemic infection with herpes simplex virus type 2. Arch Virol (1978) 0.86
Effect of delta 9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig. Proc Soc Exp Biol Med (1986) 0.85
Mechanisms of intrinsic macrophage--virus interactions in vitro. Microb Pathog (1990) 0.85
The effect of stimulants and depressants of reticuloendothelial activity on drug metabolism. J Reticuloendothel Soc (1971) 0.85